• Vancouver Tech Journal
  • Posts
  • Inside Karl Pringle's plan to disrupt the centuries-old approach to drug therapy — and save thousands of lives in the process

Inside Karl Pringle's plan to disrupt the centuries-old approach to drug therapy — and save thousands of lives in the process

The CEO of GenXys on how his startup — through science and software — will put an end to one-size-fits-all treatments and bring prescriptions into the future.

Author

William Johnson
December 14, 2021

logo

Become a VTJ Insider to keep reading.

Become a paying subscriber of Vancouver Tech Journal to get access to this post and other subscriber-only content.

Upgrade

A subscription gets you:

  • 🧠 Monthly members-only workshops and social events with investors, founders, and operators
  • 🔑 Exclusive content: In-depth stories that you won’t find anywhere else
  • 🗓️ 50% off all our Vancouver Tech Journal events
  • 🎟 First access to events we put on
  • ♥️ Supporting Vancouver's tech community
Already a subscriber?Sign in.